TABLE 1.
Sampleb | Loop length (cm) | Total weight of ileal loop (g) | Weight of empty ileal loop (g) | Vol of accumulated fluid (ml) | V/L |
---|---|---|---|---|---|
A | 6.55 ± 0.07 | 2.803 ± 0.025 | 1.206 ± 0.093 | 1.19 ± 0.01 | 181.70 ± 4.12 |
B | 6.32 ± 0.47 | 2.107 ± 0.213 | 1.107 ± 0.178 | 0.97 ± 0.12 | 154.48 ± 15.11 |
C | 6.68 ± 0.58 | 1.834 ± 0.434 | 1.349 ± 0.320 | 0.55 ± 0.29 | 63.61 ± 22.32 |
D | 6.50 ± 0.28 | 2.175 ± 0.182 | 1.850 ± 0.071 | 0.38 ± 0.11 | 56.31 ± 15.35 |
The ratio of accumulated fluid volume to loop length (V/L [in micrograms per centimeter]) was used to express the serum-neutralized effect on K88ad ETEC in ileal loop ligation as previously described (9). A significant difference in neutralizing K88ad ETEC in the sera from the mice immunized with plant-expressed recombinant FaeG was observed in comparison with the sera from the mice immunized with nontransgenic tobacco extracts.
A, K88ad ETEC not treated by sera; B, K88ad ETEC treated with the sera of mice immunized with nontransgenic plant leaf extract; C, K88ad ETEC treated with the sera of mice immunized with transgenic plant leaf extract; D, physiological saline solution instead of K88ad ETEC.